Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511Fax+1 507-266-4972
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2016 - 2019
- Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 2013 - 2016
- Nanjing UniversityClass of 2007
Certifications & Licensure
- MN State Medical License 2016 - 2025
- NJ State Medical License 2014 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- 519 citationsTreatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis.Yucai Wang, Shouhao Zhou, Fang Yang, Xinyue Qi, Xin Wang
JAMA Oncology. 2019-07-01 - 42 citationsp27Kip1 as a prognostic factor in breast cancer: a systematic review and meta‐analysisXiaoxiang Guan, Yucai Wang, Ruilian Xie, Longbang Chen, Jian-ling Bai
Journal of Cellular and Molecular Medicine. 2010-04-01 - 213 citationsRepresentation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 YearsNarjust Duma, Jesus Vera Aguilera, Jonas Paludo, Candace L. Haddox, Miguel Gonzalez Velez
Journal of Oncology Practice. 2018-01-01
Abstracts/Posters
- BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of ProgressionYucai Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Role of Imaging in Predicting Time to First Treatment and Overall Survival in Individuals with CLL-like High Count Monoclonal B-Cell LymphocytosisYucai Wang, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Outcomes of stem cell transplant in patients with Richter transformation.2019 ASCO Annual Meeting - 6/1/2019
- Efficacy of frontline treatment regimens in follicular lymphoma: A network meta-analysis of phase III randomized controlled trials.2019 ASCO Annual Meeting - 6/1/2019
- Clinical Characteristics and Outcomes of Chronic Lymphocytic Leukemia Patients with Richter Transformation2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- MCL: Event-Free Survival at 2 Years Bodes WellDecember 23rd, 2022
- Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status with Survival Benefit of Cancer Immunotherapy in Randomized Clinical TrialsAugust 3rd, 2020
- Should Patients with DLBCL and Concurrent FL Be Included in Clinical Trials?August 8th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: